Versor Investments LP Fulgent Genetics, Inc. Transaction History

Versor Investments LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$23.64 - $30.27 $162,808 - $208,469	-6,887 Reduced 29.46%	16,493 $476,000
Q3 2023 Nov 06, 2023	BUY	$26.74 - $40.81 $405,565 - $618,965	15,167 Added 184.67%	23,380 $625,000
Q2 2023 Aug 07, 2023	SELL	$28.52 - $40.7 $291,702 - $416,279	-10,228 Reduced 55.46%	8,213 $304,000
Q1 2023 May 05, 2023	BUY	$29.39 - $36.27 $259,102 - $319,756	8,816 Added 91.59%	18,441 $575,000
Q4 2022 Jan 30, 2023	SELL	$29.23 - $40.28 $717,158 - $988,269	-24,535 Reduced 71.82%	9,625 $286,000
Q3 2022 Oct 25, 2022	BUY	$37.92 - $63.74 $529,439 - $889,937	13,962 Added 69.13%	34,160 $1.3 Million
Q2 2022 Jul 27, 2022	BUY	$47.98 - $62.75 $378,658 - $495,223	7,892 Added 64.13%	20,198 $1.1 Million
Q1 2022 May 04, 2022	BUY	$49.85 - $96.11 $613,454 - $1.18 Million	12,306 New	12,306 $768,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.